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Abstract
Background—Population-based research on heart failure (HF) is hindered by lack of consensus
on diagnostic criteria. Framingham (FRM), National Health and Nutrition Examination Survey
(NHANES), Modified Boston (MBS), Gothenburg (GTH), and International Classification of
Disease, 9th Revision, Clinical Modification (ICD-9-CM) code criteria do not differentiate acute
decompensated heart failure (ADHF) from chronic stable HF. We developed a new classification
protocol for identifying ADHF in the Atherosclerosis Risk in Communities (ARIC) Study and
compared it with these other schemes.
Methods and Results—A sample of 1180 hospitalizations with a patient address in four study
communities and eligible discharge codes were selected. After assessing whether the chart
contained evidence of possible HF signs, 705 were fully abstracted. Two independent reviewers
classified each case as ADHF, chronic stable HF or no HF using ARIC classification guidelines.
Fifty-nine percent of cases met ARIC criteria for ADHF and 13.9% and 27.1% were classified as
chronic stable HF or no HF, respectively. Among events classified as HF by FRM criteria, 68.4%
were validated as ADHF, 9.6% as chronic stable HF and 21.9% as no HF. However, 92.5% of
hospitalizations with a primary ICD-9-CM 428 “heart failure” code were validated as ADHF.
Sensitivities of comparison criteria to classify ADHF ranged from 38 to 95%, positive predictive
values from 62 to 92%, and specificities from 19 to 96%.
Conclusions—Although comparison criteria for classifying HF were moderately sensitive in
identifying ADHF, specificity varied when applied to a randomly selected set of suspected HF
hospitalizations in the community.
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Heart failure (HF) is a complex clinical syndrome resulting from a structural or functional
cardiac disorder that impairs the ability of one or both ventricles to fill with or eject blood
sufficiently to meet the needs of the body. There is no universally accepted definition of
HF 1–2. Signs and symptoms may differ depending on the level of systolic or diastolic
dysfunction and further complicate disease classification 3–4. Various diagnostic criteria are
published, and comparisons between these criteria report mixed results 5–14. Population-
based studies in HF are challenged by the lack of clear diagnostic consensus, making
estimates of prevalence and incidence difficult to interpret and compare 15–18. Furthermore,
currently available classification criteria do not differentiate acute decompensated HF
(ADHF) episodes from other clinical events accompanied with chronic stable HF.
Separating acute from chronic HF in population based studies would enhance our
understanding of prediction and prevention of HF as well as provide better estimates of
trends of the HF burden in the general population. In 2005, The Atherosclerosis Risk in
Communities (ARIC) Study began surveillance of HF and developed a process to classify
hospitalizations for ADHF and chronic stable HF. The purpose of this report is to describe
the ARIC HF classification guidelines and compare its classification of ADHF and chronic
stable HF with five established diagnostic schemes for HF.
Methods
Beginning in 2005, the ARIC Study conducted continuous, retrospective surveillance of
hospital discharges for HF for all residents age 55 years and older in four US communities:
Forsyth County, North Carolina; the city of Jackson, Mississippi; eight northwest suburbs of
Minneapolis, Minnesota; and Washington County, Maryland. In 2005, there were 31
hospitals serving the four ARIC communities. The combined population in 2005 for these
regions was approximately 177,000 men and women 55 years of age or older. Because of
the small number of hospitalizations in the sample among race/ethnic groups other than
black or white (n=55), we categorized these as white for the purposes of these analyses.
Annual electronic discharge indices were obtained from all hospitals admitting residents
from the four ARIC communities. Discharges meeting eligibility criteria were sampled from
these files. A hospitalization was considered eligible for validation as a HF event based on
its International Classification of Disease, 9th Revision, Clinical Modification (ICD-9-CM)
code, age, gender, race, and residence in the community surveillance area. Target primary or
secondary hospital discharge diagnoses codes included: heart failure (428), rheumatic heart
disease (398.91), hypertensive heart disease- with congestive heart failure (402.01, 402.11,
402.91), hypertensive heart disease and renal failure- with CHF (404.01, 404.03, 404.13,
404.91, 404.93), acute cor pulmonale (415.0), chronic pulmonary heart disease, unspecified
(416.9), other primary cardiomyopathies (425.4), acute edema of lung, unspecified (518.4),
dyspnea and respiratory abnormalities (786.0). Sampling probabilities were created to
optimize variance estimates around event rate estimates with a pre-set maximum number of
cases to be abstracted in 2005 of 1499 (See Supplemental Methods). This fixed number of
abstractions was estimated and set based on a target number (n=500) of hospitalized events
that could be investigated and validated considering available resources and time
constraints. All analyses were weighted to account for the sampling probabilities.
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Centrally trained and certified staff abstracted data from eligible medical records in two
steps. First, the record was reviewed for any evidence of relevant HF symptoms (i.e. new
onset or worsening of shortness of breath, edema, paroxysmal nocturnal dyspnea, orthopnea,
or hypoxia) or any mention by the treating physicians of HF as the reason for the
hospitalization. If the hospitalization included such evidence, a second more detailed
abstraction of the medical record was completed. Detailed abstraction included recording:
evidence of new onset of symptoms, history of HF, general medical history, physical exam
signs and symptoms, diagnostic tests (chest X-ray, echocardiogram, cardiac catheterization,
coronary angiography, cardiac radionuclide ventriculogram, cardiac magnetic resonance
imaging, cardiac CT scan, stress test), biomarkers (brain natriuretic peptide (BNP), N-
terminal pro-hormone brain natriuretic peptide (pro-BNP)), and medications. Data
abstracted included required elements of four diagnostic criteria commonly used in
comparative studies: Framingham (FRM) 5, modified Boston (MBS) 6, National Health and
Nutrition Examination Survey (NHANES) 8, and Gothenburg (GTH) 7. See Supplemental
Methods. A fifth HF diagnostic scheme using ICD-9-CM coding was also used. Abstractors
made copies of sections of the medical record (discharge summary, history and physical
report, admission note, and imaging reports) for use by the ARIC HF Classification
Committee. The inter-abstractor agreement rate for determining whether or not to conduct
detailed abstraction in a quality control sample was 99%.
In addition to a HF classification based on the five comparison schemes mentioned above
(FRM, MBS, NHANES, GTH, and, ICD-9-CM) each hospitalization eligible for full
abstraction was independently reviewed by two centrally trained and certified physicians on
the ARIC HF Classification Committee. The reviewers were provided a report of the
abstracted data as well as the copied materials noted above. Each reviewer was provided a
summary of the abstracted data noted above (including measurement of ejection fraction and
biomarkers) and the copied portions of medical records, and in light of the guidelines below
classified each hospitalization into one of five categories: definite ADHF, possible ADHF,
chronic stable HF, HF unlikely, or unclassifiable. Physicians were trained and certified to
follow the ARIC classification guidelines were randomly assigned cases to review. A single
physician adjudicator (Chair of the ARIC HF Classification Committee) resolved
disagreements. For the purpose of this report we combined cases classified as either definite
or possible ADHF into one category designated as ADHF.
ARIC Heart Failure Event Classification Guidelines
Acute Decompensated Heart Failure
Definite ADHF required clear evidence either from symptoms, signs, imaging or treatment
of an acute exacerbation, worsening or new onset of symptoms or other decompensated
circulatory state. Evidence of a decompensated state included augmentation of therapy for
worsening HF signs or symptoms, documentation of subsequent in-hospital control of
symptoms by therapy, documentation of the specificity of HF for decompensated state as
opposed to other co-morbidities (e.g. chronic obstructive pulmonary disease (COPD), end-
stage renal disease). For a classification of definite ADHF, evidence that the HF treatment
(e.g. diuresis) was the main treatment that resulted in improvement is required. For example,
control of symptoms by therapy would include diuresis followed by relevant weight loss,
clinical improvement in symptoms or of pulmonary edema on chest x-ray, or evidence that
the patient no longer requires oxygen. A case was considered possible ADHF if the presence
of co-morbidity could also account for the acute symptoms or if there was not enough
information to classify as definite ADHF. For example, in cases in which renal failure,
chronic COPD, or pneumonia may also be the etiology of the presentation, or where
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multiple treatments are provided that result in clinical improvement of symptoms (e.g.
antibiotics for possible pneumonia, nebulizers for possible COPD, and diuretics for possible
HF), then a classification of possible ADHF is preferred.
Chronic Stable Heart Failure
Chronic stable HF required evidence of compensated HF signs and symptoms controlled by
therapy with no evidence of therapy augmentation or symptom worsening during the
hospitalization. Evidence of left ventricular systolic dysfunction (ejection fraction < 50%)
with no HF symptoms was sufficient for classification as chronic stable HF. Asymptomatic
diastolic dysfunction was not sufficient for a classification as chronic stable HF.
Heart failure unlikely and unclassifiable events
Hospitalizations were classified as no HF if the available documentation in the medical
record indicated directly or indirectly that heart function was normal. A designation of
unclassifiable was usually used in cases were medical records were insufficient to
differentiate between a classification of chronic stable HF and no HF or in the infrequent
case of missing medical records. For the purposes of these analyses, cases classified as HF
unlikely or determined to be unclassifiable were combined as no HF.
Data Analysis
We computed reliability and validity metrics comparing ARIC classification and the five
comparison diagnostic schemes using two rubrics. First, we compared a three-level ARIC
HF category (ADHF, chronic stable HF, no HF) with results of the algorithms using FRM,
MBS, NHANES, GTH, and ICD-9-CM heart failure schemes. Second, we created a more
general two-level ARIC HF classification combining ADHF together with chronic stable HF
and compared this two-level ARIC category (i.e. ADHF or chronic stable HF, no HF) with
the above criteria.
Calculations of percent agreement and kappa coefficients transformed the 3-level MBS and
5-level GTH classifications into dichotomous groups (HF, no HF). We combined GTH
criteria levels 2 and 3 together as a positive classification for HF. For MBS criteria, the
categories of definite and probable HF were combined. NHANES and FRM criteria were
retained as their original two-level categories. We also created two ICD-9-CM code-based
criteria for comparison purposes. One considered the presence of an ICD-9-CM 428 code in
any position on the discharge list as sufficient to be classified as HF and the other required a
428 code as the primary discharge diagnosis.
Sensitivity, positive predictive value, and specificity using the ARIC HF classification as the
gold standard were computed in the standard fashion. The comparability ratio reported was
computed as the ratio of the number of HF events defined by established criteria to the
number of HF events validated as determined by the ARIC HF guidelines. We defined
specificity as the proportion of sampled and reviewed hospitalizations that were classified
by ARIC HF review as non-HF events that were classified as non-HF by the comparison
criteria.
We assessed percent agreement between ARIC HF classification and the comparison criteria
using standard methods 19 and chance-corrected agreement by kappa coefficients 20. Chi-
square tests on the weighted proportions were used to determine statistical significance of
differences in percent of events validated by ARIC classification.
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In 2005, residents age 55 years or older in the four ARIC communities had 11,544 hospital
discharges with ICD-9-CM diagnosis codes within our target list. We selected a random
sample of 1499 hospitalizations for investigation. After exclusion of hospitalizations where
medical records were unavailable (n=16), that contained ineligible patient addresses (n=303)
or that lacked relevant HF symptoms needed for full abstraction (n=475), we conducted
detail abstraction and validation of 705 hospitalizations. The agreement rate between two
physician reviewers for classifying an event was 75% for hospitalization with an ICD-9-CM
428 code and 86% for hospitalizations without an ICD-9-CM 428 code. Table 1 shows the
classification of all sampled HF hospitalizations combining those fully abstracted and
reviewed by ARIC (n=705) with those hospitalizations not eligible for full abstraction and
not reviewed by the committee (n=475). For the purposes of this analysis, we categorized
this latter group as non-HF hospitalizations. For all hospitalizations, 36% were classified as
ADHF, 8.5% as chronic stable HF, and 10.2% as no HF. A small percent (6.3%) were not
classifiable by the classification committee and 38.9% did not meet initial screening to merit
full review and are considered hospitalizations for reasons other than for HF. Men, blacks,
and hospitalizations with an ICD-9-CM 428 code were more likely to be validated as ADHF.
Differences in the percent of events validated as ADHF across the four communities were
not statistically significant. Among all sampled hospitalizations (including those not meeting
the full abstraction criteria) with an ICD-9-CM 428 code in any position, 38.5% were
validated as acute decompensated HF and 9.1% as chronic stable HF. Of note, 16.8% of
cases without an ICD-9-CM 428 code were validated as ADHF by ARIC review. The
majority (88.3%) of hospitalizations with an ICD-9-CM 428 code as the primary discharged
diagnosis were validated as ADHF.
The percent of hospitalization meriting full abstraction and review that were validated as HF
using each of the comparison classification criteria is shown in Table 2. Of the
hospitalizations meeting FRM criteria for HF, 68.4% were classified as ADHF by ARIC
review. An additional 9.6% were classified as chronic stable HF and 21.9% were determined
to be hospitalization for conditions other than HF. Approximately one-quarter of
hospitalizations determined not to be HF by FRM criteria were actually classified as ADHF
by ARIC review. A similar pattern was seen when comparing ARIC review with MBS,
NHANES, and GTH criteria or to presence of an ICD-9-CM 428 code in any position.
However, among hospitalizations with a primary discharge diagnosis of HF (ICD-9-CM
428), 93.0% were validated as ADHF.
The crude agreement between the various classifications schema was moderate (Table 3). As
expected, the agreement between ARIC review and the comparison classification criteria
increased when the ARIC review endpoints of ADHF plus chronic stable HF were
combined. Chance corrected estimates of agreement (kappa) between criteria were generally
poor.
Framingham criteria were 90% sensitive and 40% specific for classifying ADHF (Table 4).
These combined with a positive predictive value of 68% resulted in a comparability ratio of
1.31. The sensitivity and specificity of FRM criteria was slightly reduced to 83% and 37%,
respectively and the positive predictive value increased from 68% to 78% when compared to
the combined ARIC endpoint of either (ADHF plus chronic stable HF). As a result, the
comparability ratio improved to 1.06 when FRM criteria are used to estimate the presence of
either ADHF or chronic stable HF. Similar results were seen for MBS, NHANES and GTH
criteria. Although the sensitivity of an ICD-9-CM 428 code in any position was slightly
higher (sensitivity = 95%) compared to the other established criteria, its comparability ratio
for classifying either AHDF deviated from unity more than the other criteria (comparability
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ratio =1.52). Presence of a primary ICD-9-CM 428 discharge code had high specificity
(95%), but poor sensitivity (43%) for ADHF.
The concordance of hospitalizations classified as HF by FRM, ARIC, or primary discharge
diagnosis code is shown on the Figure. Only 28% of cases meet all three criteria and an
equal proportion (28%) met FRM criteria but not ARIC or discharge code criteria. A small
proportion of cases (5%) were called HF by ARIC when FRM or discharge code criteria
indicated a non-HF event. The percent overlap between these three classifications increased
to 52% when expanding the discharge code definition to include a 428 code listed in any
position (data not shown).
Discussion
The ARIC HF classification guidelines described in this paper provide a more detailed
categorization of HF hospitalizations than currently available criteria. The ARIC
classification was specifically designed to differentiate ADHF from hospitalizations
associated with chronic or stable HF, a feature not possible with the other commonly used
criteria. Thus, the ARIC HF classification protocol is likely to result in improved accuracy
of the rates of ADHF hospitalizations (although, because many people with chronic HF are
not hospitalized at the time of diagnosis, it will not necessarily result in improved accuracy
of total HF incidence). Although the other criteria were not designed for this level of
granularity in classification, evaluating their validity in classifying ADHF as well as total
HF may help inform interpretation of previous work as well as shape future studies of HF.
We found that the five comparison diagnostic criteria were highly sensitive in identifying
ADHF but had poor specificity. Comparison criteria had similar levels of accuracy with one
another in identifying any HF (decompensated or chronic stable HF). In contrast, a primary
ICD-9-CM 428 discharge code had poor sensitivity in identifying either decompensated or
any HF but was highly specific for both. These measures of validity combined with the
moderate to poor agreement among all classification schemes underscore the lack of
consensus on epidemiologic definitions of HF.
The limited population-based data available on the incidence of HF use varying
criteria9, 15–17, 21–26. Although the FRM criteria has emerged as the standard for the
identification of HF in many epidemiologic studies; studies disagree about which is
diagnostically superior27. In studies using echocardiographic evidence of left ventricular
dysfunction as a gold standard, FRM criteria were found to have high sensitivity (92%) but
moderate specificity (79%)4, 28. In contrast, FRM criteria were reported to have lower
sensitivity and specificity in a study of suspected HF patients who were referred for
radioisotopic assessment of systolic ventricular function 29.
Remes and colleague reported on cases of clinically suspected HF30 in comparison with
Boston criteria’s HF diagnosis and found a relatively high sensitivity and specificity (80%
and 92%, respectively). In contrast, Mosterd and colleagues (1997) report that the sensitivity
of FRM, MBS, GTH, NHANES classifications schemes relative to clinical cardiologist’s
diagnosis vary considerably 13. In a large community-based study of seven HF criteria using
clinical physician review as the gold standard, all criteria investigated had low sensitivity
(range 46% to 84%) yet high specificity (range 81% to 96%) 27.
Studies that assess agreement among the criteria are equally as varied in their conclusions.
Substantial concordance among the MBS FRM, NHANES schemes (kappa coefficients
generally > 0.60) have been reported 27, 30, but agreement between GTH and the others are
poor. Our findings of poor agreement among criteria are supported by previous work
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comparing FRM criteria, European Society of Cardiology (ESC) criteria and independent
physician review 11.
When the FRM criteria were compared with those developed by the Cardiovascular Health
Study (CHS), the FRM criteria resulted in an incidence estimate approximately 23 percent
greater than the estimate calculated using the CHS criteria31. In another setting, HF
incidence varied using Boston, FRM, GTH and ESC criteria (12%, 11%, 21%, and 9%,
respectively) 11. Boston criteria more accurately identified HF cases (using physician review
as gold standard) than GTH, FRM, and ESC criteria and also were better at predicting
cardiovascular death, incident disability, and hospitalizations 11. The incorporation of
echocardiography or biomarkers evidence in physician review, neither of which are included
in most established diagnostic criteria may result in earlier detection of less advanced cases
and may result in lead-time bias. 18, 32
Elements included in each of the comparison HF criteria differ. While all four HF
incorporate patient’s medical history and physical examination, a chest X-ray is not required
in the GTH criteria, and the FRM score is the only one to incorporate vital capacity. Many
of the current criteria rely on elements frequently missing in routine medical records. The
FRM and Boston criteria rely heavily upon the presence of pulmonary congestion to
diagnose HF; however, this may limit the ability to adequately classify HF in the presence of
preserved systolic function. 3, 29 Key differences in the ARIC HF classification guidelines
compared to HF criteria scores are that it incorporates more current diagnostic tests, which
have been shown to improve prognostic ability 10, 17, 33–34. These diagnostic methods are
becoming increasingly available for clinical use 35 as well as increasingly required in HF
definitions used in clinical trials14.
The differentiation between ADHF and chronic stable HF is crucial for epidemiologic
studies of HF etiology. HF mortality rates differ based on the underlying cause of HF 36 and
can vary by the population studied and the differential criteria used making proper
categorization of HF essential. 25 While some studies exclude patients who developed HF
secondary to admission for another illness16, others include them but do not adequately
determine these underlying conditions25. Given that substantial race/ethnic 37 and gender 38
differences in HF etiology exist, accurate classification is also critical in measuring and
preventing HF in different populations. Clinicians and policy makers are concerned with
reducing HF rehospitalizations. Improved epidemiologic methods for differentiating
between ADHF and chronic stable HF would improve our accuracy in defining
rehospitalizations due to ADHF and aid the examination of outcomes and how they related
to clinical practice, therapy advances and policies.
Studies employing ICD-9-CM diagnosis codes to define HF are not consistent. Some define
HF as a primary discharge code of 428; others include patients with 428 listed in any
position. In our study, 39% of hospitalizations with a 428 code in any position were
categorized as ADHF and 9% were categorized as chronic stable HF. Further, 12% of cases
with a primary discharge diagnosis of HF were determined to not have HF. We found that
17% of cases without an 428 code were validated as ADHF, suggesting that limiting the
definition of HF to a code of 428 may result in inaccurately low estimates of HF. Indeed,
studies using claims databases often use the presence of primary diagnosis codes 402 or 404
in addition to 428 to define HF events 39–40. In our study, adding these additional code
groups did not appreciably change the validation estimates (data not shown).
Strengths and Limitations
Diagnostic accuracy was rigorously tested, with each case being subject to review by two
independent physician reviewers. However, a number of study limitations must be
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considered. In some chronic HF cases, it may be difficult to determine whether the patient’s
status matches the baseline HF status or indicates some deterioration. In these cases, the
totality of the evidence provided was taken into consideration. A potential limitation in all
studies of this type is that the diagnostic accuracy of criteria depends on the population
characteristics including the prevalence of HF.
Conclusions
An improved method of diagnosis of HF is critical if primary and secondary prevention
efforts are to target individuals at risk for HF15. The ARIC HF classification guidelines,
created for use in ongoing community and cohort surveillance, provide a methodology for
the diagnosis of hospitalized HF and differentiate ADHF and chronic stable HF. These
methods could be applied in other study populations where access to medical records is
feasible and some training of reviewers to follow the guidelines presented is practical. We
found that a principle ICD-9-CM code for heart failure (code 428) was highly specific but
had poor sensitivity for ADHF using the ARIC classification. A next step in the assessment
of this classification system is to investigate its accuracy for the prediction of outcomes such
as mortality, disability and future HF-related hospitalizations and ultimately to evaluate
disease trends.
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